Prospective, multicentre, international Registry of male and female patients newly diagnosed with Atrial Fibrillation and treated with Rivaroxaban Read more about Prospective, multicentre, international Registry of male and female patients newly diagnosed with Atrial Fibrillation and treated with Rivaroxaban
(FLASH study)A 12-week treatment, multi-center, randomized, doubleblind,double-dummy, parallel group study to assess the efficacy and safety of switching fromsalmeterol/fluticasone to QVA149 (indacaterolmaleate/glycopyrronium bromide) in symptomatic COPD patients Read more about (FLASH study)A 12-week treatment, multi-center, randomized, doubleblind,double-dummy, parallel group study to assess the efficacy and safety of switching fromsalmeterol/fluticasone to QVA149 (indacaterolmaleate/glycopyrronium bromide) in symptomatic COPD patients
XALIA LEA- Xarelto® for Long-term and Initial Anticoagulation in VenousThromboembolism (VTE) in Latin America,EMEA and Asia Read more about XALIA LEA- Xarelto® for Long-term and Initial Anticoagulation in VenousThromboembolism (VTE) in Latin America,EMEA and Asia
Prospective Multicentre Observational Registry Of Treatments And Outcomes In Patients With Chronic Read more about Prospective Multicentre Observational Registry Of Treatments And Outcomes In Patients With Chronic
Early Goal Directed Sedation vs. Standard Care Sedation Read more about Early Goal Directed Sedation vs. Standard Care Sedation
Efficacy of Different Mouthwashes in the Reduction of Halitosis: A Randomized, Double Blind, Placebo-Controlled, Crossover Clinical Trial Read more about Efficacy of Different Mouthwashes in the Reduction of Halitosis: A Randomized, Double Blind, Placebo-Controlled, Crossover Clinical Trial
easypod connect: A regional, Multicentre, Observational study to evaluate Adherenceand Long Term Outcomes of Therapy in Paediatric subjects using “easypodTM” electromechanical device for growth hormone treatment Read more about easypod connect: A regional, Multicentre, Observational study to evaluate Adherenceand Long Term Outcomes of Therapy in Paediatric subjects using “easypodTM” electromechanical device for growth hormone treatment
Observational Prospective STudy In Management of 1st line KRAS Wildtype mCRC with Erbitux™ (Cetuximab)- OPTIM1SE Read more about Observational Prospective STudy In Management of 1st line KRAS Wildtype mCRC with Erbitux™ (Cetuximab)- OPTIM1SE
AWARE-AMAC (A World-wide Antihistamine-Refractory chronic urticaria patient Evaluation in Asia pacific, Middle-east and African Countries (AWARE-AMAC): A noninterventional study to collect data on the management and clinical impacts of chronic urticaria in patients refractory to H1-antihistamine therapy Read more about AWARE-AMAC (A World-wide Antihistamine-Refractory chronic urticaria patient Evaluation in Asia pacific, Middle-east and African Countries (AWARE-AMAC): A noninterventional study to collect data on the management and clinical impacts of chronic urticaria in patients refractory to H1-antihistamine therapy
Non transfusion dependent Thalassemia Drug Registry Read more about Non transfusion dependent Thalassemia Drug Registry
